1. Academic Validation
  2. A mass spectrometry-based strategy allows signature metabolite identification in tear fluid from people with diabetic cataracts

A mass spectrometry-based strategy allows signature metabolite identification in tear fluid from people with diabetic cataracts

  • Nat Commun. 2025 Nov 21;16(1):10246. doi: 10.1038/s41467-025-65082-7.
Ziheng Qi # 1 Miao Wang # 2 3 Chenxi Yan # 2 3 Yinbing Zhao 1 Yanhui Wang 1 Xiaonan Chen 1 Shunxiang Li 4 Wenbo Zhuang 2 3 Weikang Shu 1 Yating Wang 1 Yingying Lin 1 Jiaxin Hou 1 Tao Guo 5 6 Xianqun Fan 7 8 Yun Su 9 10 Jingjing Wan 11
Affiliations

Affiliations

  • 1 School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, PR China.
  • 2 Department of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, PR China.
  • 3 Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, PR China.
  • 4 School of Biomedical Engineering, and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, PR China.
  • 5 Department of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, PR China. [email protected].
  • 6 Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, PR China. [email protected].
  • 7 Department of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, PR China. [email protected].
  • 8 Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, PR China. [email protected].
  • 9 Department of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, PR China. [email protected].
  • 10 Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, PR China. [email protected].
  • 11 School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, PR China. [email protected].
  • # Contributed equally.
Abstract

Metabolic biomarker discovery in trace body fluids remains a significant challenge, toward molecular diagnosis and pathology studies in many diseases. Especially for eye-related diseases, such an approach based on non-invasive tear fluids remains an unsatisfied urgent need in ophthalmology. Here we construct a metabolic biomarker panel from 10 nL of tear fluids in seconds using nanoparticle-enhanced laser desorption/ionization -mass spectrometry (MS), which achieves an area under the curve of 0.923 for discriminating diabetic cataracts from alone age-related cataracts. Importantly, we integrate liquid chromatography -MS into the above analysis process to construct an integrated strategy, allowing reliable metabolite annotation by nanoliter sample volume without compromising high throughput. Further, using matched aqueous humors, we identify 1,5-anhydroglucitol as a biomarker of diabetic cataracts, revealing its protective effect against high glucose-induced lens oxidative stress and opacification, as a demonstration of the metabolic reprogramming. Our approach can be universally applied to uncover biomarkers using trace body fluid, promising next-generation metabolic reprogramming identification.

Figures
Products